Catalyst Wire Dossier Catalyst Wire Dossier

Ratutrelvir

Ratutrelvir · Traws Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ratutrelvir, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19 [Phase 2]

See pricing